Home merck
 

Keywords :   


Tag: merck

Merck, Ferring Pharmaceuticals and the World Health Organization Working Together to Prevent Excessive Bleeding in Women after Childbirth

2014-04-04 14:00:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. Post-partum Hemorrhage Is Leading Cause of Mothers Dying WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Ferring Pharmaceuticals today announced their collaboration with the World Health Organization (WHO) to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding (post-partum hemorrhage) in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates (ICH climatic zone IV). Language: English Contact: MerckMedia:Jennifer Allen Woodruff, 267-305- 3550orLainie Keller, 908-423-4187orInvestor:Carol Ferguson, 908-423-4465orFerring Media:Helen Gallagher, +41 58 301 0051orPatrick Gorman, +41 58 301 0053 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: world health working women

 

FDA OKs 1st dissolving immunotherapy tablet for seasonal allergies; 2 from Merck ...

2014-04-02 17:51:17| Biotech - Topix.net

The U.S. Food and Drug Administration has approved the first tablet for gradually reducing hay fever allergy symptoms, an alternative to uncomfortable allergy-desensitizing shots.

Tags: from 1st seasonal tablet

 
 

Merck Serono's CEO BelA n Garijo - Enabling Risk And Refusing To Play It Safe

2014-04-01 21:13:45| Biotech - Topix.net

Sitting on the secondlevel balcony of the grand ballroom in the historic New York Waldorf-Astoria, my vantage point provides a bird's-eye view of the floor below.

Tags: it play safe risk

 

Merck replacing CFO with Baxter executive in April

2014-03-28 03:59:15| Biotech - Topix.net

Drugmaker Merck & Co. has named a new chief financial officer to succeed Peter N. Kellogg, who's held the post for seven years.

Tags: april executive replacing cfo

 

Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007

2014-03-27 12:20:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Robert M. Davis, 47, as executive vice president and chief financial officer, effective April 23, 2014. Davis, who will also oversee corporate strategy and corporate business development, will succeed Peter N. Kellogg, 58. Language: English Contact: MerckMedia:Steven Cragle, 908-423-3461Pam Eisele, 267-305-3558orInvestors:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: the since role robert

 

Sites : [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] next »